Clinical Trials Directory

Trials / Completed

CompletedNCT04390698

Opioid Free Anesthesia in Breast Cancer Surgery

Opioid Free Anesthesia in Breast Cancer Surgery: a Prospective Randomized Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
80 (actual)
Sponsor
Peking University People's Hospital · Academic / Other
Sex
Female
Age
20 Years – 75 Years
Healthy volunteers
Not accepted

Summary

A comparison of incidences of postoperative nausea and vomiting (PONV) , postoperative pain severity and recovery parameters in breast cancer patients receiving opioid or opioid-free general anesthesia.

Detailed description

Breast cancer is one of the most common oncologic diagnosis in women. Surgery is traditionally performed under general anesthesia with opioid-based analgesia. It is associated with higher incidences of PONV, more severe acute postoperative pain and increased incidences of chronic pain. The possibility of higher risk of metastasis has also been reported. The purpose of our study is to compare the opioid-free general anesthesia with the opioid-based general anesthesia with respect to the quality of recovery, postoperative pain and cancer recurrence and metastasis.

Conditions

Interventions

TypeNameDescription
PROCEDUREparavertebral blockParavertebral block will be performed at T2,T4 level on the surgical side using out-of-plane approach under ultrasound-guided, with 0.4% ropivacaine 20ml at each injection site.
DRUGopioid free anesthesiapropofol, lidocine and muscle relaxant will be used for induction, after laryngeal mask airway insertion, general anesthesia will be maintained.
PROCEDUREsham blockLocal infiltration at the same site of paravertebral block will be performed, with 1% lidocaine 3ml on each injection site.
PROCEDUREopioid general anesthesiapropofol, sufentanil and muscle relaxant will be used for induction, after laryngeal mask airway insertion, general anesthesia will be maintained .

Timeline

Start date
2020-07-01
Primary completion
2021-03-15
Completion
2022-03-15
First posted
2020-05-15
Last updated
2022-04-05

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04390698. Inclusion in this directory is not an endorsement.